At the PIF Annual Conference on Wednesday 25 May 2016 delegates will be able to choose to attend two of six Case Study Sessions on a variety of topics, that have involved partnership working to improve healthcare information and support.
We will be showcasing each Case Study Session over the next month. Below is an overview of the Case Study that will be presented by Janssen UK & Ireland.
You can find out more details about the conference and how you can attend here:www.pifonline.org.uk/2016-conference
Partnership working with the pharmaceutical industry
At Janssen our vision, guided by the Johnson & Johnson Credo, is to help people to lead healthier and happier lives. We believe that working in close partnership with patient advocacy groups gives us a greater understanding of the needs of patients and their families.
Our patient group promise defines our commitment to working in a transparent and ethical way to support sustainable relationships. This case study will give an insight and guide to some of the initiatives Janssen are currently working on, offering opportunity for discussion around industry partnering.
Barbara Donalson – Public Affairs Manager, Janssen UK & Ireland
Barbara is the Public Affairs Manager at Janssen UK and is part of the Communications and Government Affairs team. Her role involves patient engagement and advocacy working directly with Patient Organisations, NGOs and Healthcare Teams to develop and support projects and partnerships that deliver valued patient outcomes.
Barbara has spent the last 15 years working in a variety of roles at Janssen in the UK and Europe, including sales & marketing, business development and market access. She has developed a variety of patient focussed initiatives and support programmes which have a strong focus on supporting inequalities in healthcare and ensuring access to medicines for people when they need them.
James Fitzpatrick, Government Affairs & Patient Advocacy, Janssen UK & Ireland
James joined the Janssen UK communications team as Communications and Government Affairs Manager in 2014 to lead on haematology communications and support the remaining therapy areas in the government affairs field. In early 2015 James was given the responsibility for patient advocacy in the UK as well as retaining the government affairs responsibility. This compliments James’ experience of having worked in both the charity and political worlds.
Prior to working at Janssen, James had spent several years working in the third (charity) sector, most recently for an auto-immune patient group heading up the government affairs and campaigns. For the majority of his career prior to moving over to pharma, James’ experience is from his time in political communications covering media relations, public engagement, ministerial events, speech writing, campaigns and crisis management and consultancy.